210 related articles for article (PubMed ID: 25377076)
1. Endothelin-a receptor antagonism after renal angioplasty enhances renal recovery in renovascular disease.
Chade AR; Tullos N; Stewart NJ; Surles B
J Am Soc Nephrol; 2015 May; 26(5):1071-80. PubMed ID: 25377076
[TBL] [Abstract][Full Text] [Related]
2. Disparate effects of single endothelin-A and -B receptor blocker therapy on the progression of renal injury in advanced renovascular disease.
Chade AR; Stewart NJ; Peavy PR
Kidney Int; 2014 Apr; 85(4):833-44. PubMed ID: 24352153
[TBL] [Abstract][Full Text] [Related]
3. Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization.
Guise E; Engel JE; Williams ML; Mahdi F; Bidwell GL; Chade AR
Am J Physiol Renal Physiol; 2019 May; 316(5):F1016-F1025. PubMed ID: 30892933
[TBL] [Abstract][Full Text] [Related]
4. Chronic blockade of endothelin A and B receptors using macitentan in experimental renovascular disease.
Tullos NA; Stewart NJ; Davidovich R; Chade AR
Nephrol Dial Transplant; 2015 Apr; 30(4):584-93. PubMed ID: 25438341
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease.
Kelsen S; Hall JE; Chade AR
Am J Physiol Renal Physiol; 2011 Jul; 301(1):F218-25. PubMed ID: 21478482
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous transluminal renal angioplasty attenuates poststenotic kidney mitochondrial damage in pigs with renal artery stenosis and metabolic syndrome.
Farahani RA; Afarideh M; Zhu XY; Tang H; Jordan KL; Saadiq IM; Ferguson CM; Lerman A; Textor SC; Lerman LO; Eirin A
J Cell Physiol; 2021 May; 236(5):4036-4049. PubMed ID: 33151557
[TBL] [Abstract][Full Text] [Related]
7. Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism.
Harvey TW; Engel JE; Chade AR
Am J Nephrol; 2016; 43(2):74-84. PubMed ID: 26930122
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of percutaneous transluminal renal angioplasty with stent in elderly male patients with atherosclerotic renal artery stenosis.
Zhao J; Cheng Q; Zhang X; Li M; Liu S; Wang X
Clin Interv Aging; 2012; 7():417-22. PubMed ID: 23091375
[TBL] [Abstract][Full Text] [Related]
9. Renal Therapeutic Angiogenesis Using a Bioengineered Polymer-Stabilized Vascular Endothelial Growth Factor Construct.
Chade AR; Tullos NA; Harvey TW; Mahdi F; Bidwell GL
J Am Soc Nephrol; 2016 Jun; 27(6):1741-52. PubMed ID: 26541349
[TBL] [Abstract][Full Text] [Related]
10. [Long-term follow-up of elderly patients with atherosclerotic renal artery stenosis treated by percutaneous transluminal angioplasty with stent implantation].
Zhao JH; Cheng QL; Zhang XY
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1673-6. PubMed ID: 21914314
[TBL] [Abstract][Full Text] [Related]
11. Comparison of acute and chronic antioxidant interventions in experimental renovascular disease.
Chade AR; Krier JD; Rodriguez-Porcel M; Breen JF; McKusick MA; Lerman A; Lerman LO
Am J Physiol Renal Physiol; 2004 Jun; 286(6):F1079-86. PubMed ID: 14722019
[TBL] [Abstract][Full Text] [Related]
12. Revascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure.
Favreau F; Zhu XY; Krier JD; Lin J; Warner L; Textor SC; Lerman LO
Kidney Int; 2010 Dec; 78(11):1110-8. PubMed ID: 20463652
[TBL] [Abstract][Full Text] [Related]
13. [Significance of renal filtration fraction evaluation of renal artery stenting for atherosclerotic renal artery stenosis treatment].
Feng QC; Li X; Luan JY; Wang CM; Li TR
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 49(1):158-63. PubMed ID: 28203024
[TBL] [Abstract][Full Text] [Related]
14. Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach.
Chade AR; Kelsen S
Am J Physiol Renal Physiol; 2012 May; 302(10):F1342-50. PubMed ID: 22357917
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant intervention blunts renal injury in experimental renovascular disease.
Chade AR; Rodriguez-Porcel M; Herrmann J; Zhu X; Grande JP; Napoli C; Lerman A; Lerman LO
J Am Soc Nephrol; 2004 Apr; 15(4):958-66. PubMed ID: 15034098
[TBL] [Abstract][Full Text] [Related]
16. Kidney Intrinsic Mechanisms as Novel Targets in Renovascular Hypertension.
Eirin A; Chade AR; Lerman LO
Hypertension; 2024 Feb; 81(2):206-217. PubMed ID: 37869904
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Severe Renal Artery Stenosis with Acute Kidney Injury Requiring Hemodialysis by Percutaneous Transluminal Renal Angioplasty and Stent Implantation.
Abu-Amer N; Kukuy OL; Kunin M; Holtzman EJ; Rimon U; Dinour D; Beckerman P
J Vasc Interv Radiol; 2022 Jun; 33(6):707-714.e2. PubMed ID: 35288233
[TBL] [Abstract][Full Text] [Related]
18. Renal microvascular disease determines the responses to revascularization in experimental renovascular disease.
Chade AR; Kelsen S
Circ Cardiovasc Interv; 2010 Aug; 3(4):376-83. PubMed ID: 20587789
[TBL] [Abstract][Full Text] [Related]
19. Ischemic Nephropaty: The Role of the Renal Artery Stenosis Revascularization on Renal Stem Cells.
Cianci R; Perrotta AM; Gigante A; Errigo F; Ferri C; Cianci E; Simeoni M; Mazzaferro S; Lai S
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577867
[TBL] [Abstract][Full Text] [Related]
20. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
